ArticleJAMA2021

Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction in Patients With Chronic Immune-Mediated Inflammatory Diseases.

Konstantinos Papamichael et al.PubMed ↗Publisher ↗

No numbers read from the abstract.